Ryan Zimmerman
Stock Analyst at BTIG
(3.87)
# 624
Out of 5,126 analysts
233
Total ratings
50.51%
Success rate
9.52%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $87 → $91 | $80.65 | +12.83% | 5 | Feb 4, 2026 | |
| SYK Stryker | Maintains: Buy | $410 → $412 | $358.29 | +14.99% | 19 | Jan 30, 2026 | |
| GKOS Glaukos | Maintains: Buy | $123 → $131 | $112.52 | +16.42% | 16 | Jan 28, 2026 | |
| ISRG Intuitive Surgical | Reiterates: Buy | $616 | $488.15 | +26.19% | 23 | Jan 23, 2026 | |
| PEN Penumbra | Downgrades: Neutral | $349 | $341.02 | +2.34% | 21 | Jan 16, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $89.91 | +24.57% | 10 | Jan 8, 2026 | |
| ENOV Enovis | Initiates: Buy | $41 | $22.59 | +81.50% | 1 | Jan 6, 2026 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $9 | $3.77 | +138.73% | 10 | Dec 26, 2025 | |
| CARL Carlsmed | Reiterates: Buy | $24 | $11.67 | +105.66% | 2 | Dec 15, 2025 | |
| RBOT Vicarious Surgical | Suspends: Neutral | n/a | $1.97 | - | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $78.12 | +28.01% | 2 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $78.83 | +15.44% | 13 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.94 | +539.45% | 6 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $3.90 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.52 | +97.37% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.59 | +153.68% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.26 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $27.91 | +0.32% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $16.65 | +38.14% | 10 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $74.81 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $146.47 | +33.13% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.19 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $28.74 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $12.74 | +80.53% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $110.83 | +33.54% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.39 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $87.81 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $11.26 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $17.58 | +201.48% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $12.80 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $139.15 | +43.73% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $241.93 | +44.67% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $102.90 | +24.39% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.09 | +24.07% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.82 | +135.69% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.45 | +863.30% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $34.92 | - | 3 | Apr 2, 2020 |
GE HealthCare Technologies
Feb 4, 2026
Maintains: Buy
Price Target: $87 → $91
Current: $80.65
Upside: +12.83%
Stryker
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $358.29
Upside: +14.99%
Glaukos
Jan 28, 2026
Maintains: Buy
Price Target: $123 → $131
Current: $112.52
Upside: +16.42%
Intuitive Surgical
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $488.15
Upside: +26.19%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $341.02
Upside: +2.34%
Zimmer Biomet Holdings
Jan 8, 2026
Reiterates: Buy
Price Target: $112
Current: $89.91
Upside: +24.57%
Enovis
Jan 6, 2026
Initiates: Buy
Price Target: $41
Current: $22.59
Upside: +81.50%
Organogenesis Holdings
Dec 26, 2025
Reiterates: Buy
Price Target: $9
Current: $3.77
Upside: +138.73%
Carlsmed
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $11.67
Upside: +105.66%
Vicarious Surgical
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.97
Upside: -
Dec 2, 2025
Upgrades: Buy
Price Target: $100
Current: $78.12
Upside: +28.01%
Nov 24, 2025
Reiterates: Buy
Price Target: $91
Current: $78.83
Upside: +15.44%
Nov 21, 2025
Reiterates: Buy
Price Target: $6
Current: $0.94
Upside: +539.45%
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $3.90
Upside: -
Nov 12, 2025
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.52
Upside: +97.37%
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.59
Upside: +153.68%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $2.26
Upside: -
Nov 4, 2025
Upgrades: Buy
Price Target: $28
Current: $27.91
Upside: +0.32%
Oct 29, 2025
Reiterates: Buy
Price Target: $23
Current: $16.65
Upside: +38.14%
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $74.81
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $146.47
Upside: +33.13%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $36.19
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $28.74
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $12.74
Upside: +80.53%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $110.83
Upside: +33.54%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.39
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $87.81
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $11.26
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $17.58
Upside: +201.48%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $12.80
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $139.15
Upside: +43.73%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $241.93
Upside: +44.67%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $102.90
Upside: +24.39%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.09
Upside: +24.07%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.82
Upside: +135.69%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.45
Upside: +863.30%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $34.92
Upside: -